---
figid: PMC6097514__ott-11-4817Fig1
figlink: /pmc/articles/PMC6097514/figure/f1-ott-11-4817/
number: F1
caption: 'Targetable cell survival mechanisms.Notes: Stimulation of the BCR and its
  co-receptor CD19 results in downstream signaling via the PI3K/AKT/mTOR pathway.
  LYN and SYK are recruited to the engaged BCR, where they are activated by phosphorylation
  and initiate the cascade. PI3K recruitment occurs through mechanisms including BCAR.
  Activation proceeds via AKT to mTOR, GSK-3 and NF-κB. Additionally, stimulation
  along BTK results in further NF-κB activity. Ultimately, stimulation along the P13K/AKT/mTOR
  pathways results in increased cell survival, proliferation, metabolism, migration
  and chemokine secretion. Inhibition of PI3K acts to overt these mechanisms.Abbreviation:
  BCR, B-cell receptor.'
pmcid: PMC6097514
papertitle: 'Spotlight on copanlisib and its potential in the treatment of relapsed/refractory
  follicular lymphoma: evidence to date.'
reftext: Felix A Mensah, et al. Onco Targets Ther. 2018;11:4817-4827.
pmc_ranked_result_index: '96680'
pathway_score: 0.9042079
filename: ott-11-4817Fig1.jpg
figtitle: 'Targetable cell survival mechanisms.Notes: Stimulation of the BCR and its
  co-receptor CD19 results in downstream signaling via the PI3K/AKT/mTOR pathway'
year: '2018'
organisms: Homo sapiens
ndex: 6b4678ed-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6097514__ott-11-4817Fig1.html
  '@type': Dataset
  description: 'Targetable cell survival mechanisms.Notes: Stimulation of the BCR
    and its co-receptor CD19 results in downstream signaling via the PI3K/AKT/mTOR
    pathway. LYN and SYK are recruited to the engaged BCR, where they are activated
    by phosphorylation and initiate the cascade. PI3K recruitment occurs through mechanisms
    including BCAR. Activation proceeds via AKT to mTOR, GSK-3 and NF-κB. Additionally,
    stimulation along BTK results in further NF-κB activity. Ultimately, stimulation
    along the P13K/AKT/mTOR pathways results in increased cell survival, proliferation,
    metabolism, migration and chemokine secretion. Inhibition of PI3K acts to overt
    these mechanisms.Abbreviation: BCR, B-cell receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCL2
  - CXCL13
  - CXCL1
  - AKT3
  - CXCL3
  - AKT2
  - BCR
  - BTK
  - AKT1
  - GSK3B
  - CXCL8
  - CXCL10
  - CD19
  - PIK3CD
  - CXCL5
  - CXCL12
  - PIK3CB
  - GSK3A
  - PIK3R6
  - PRKCQ
  - CXCL14
  - PRKCG
  - PRKCH
  - PRKCI
  - LYN
  - PLCG2
  - SYK
  - CXCL9
  - PRKCZ
  - PRKD3
  - MTOR
  - CXCL6
  - CXCL11
  - PRKCE
  - PPBP
  - PIK3R3
  - NFKB1
  - PIK3R5
  - PIK3CG
  - PIK3CA
  - PRKCD
  - PF4
  - PIK3R4
  - PRKCB
  - PRKCA
  - Cancer
genes:
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: CD19
  symbol: CD19
  source: hgnc_symbol
  hgnc_symbol: CD19
  entrez: '930'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: LYN
  symbol: LYN
  source: hgnc_symbol
  hgnc_symbol: LYN
  entrez: '4067'
- word: PLCY2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6097514__F1
redirect_from: /figures/PMC6097514__F1
figtype: Figure
---
